A next generation genome sequencer has been received in the newly launched Center for Translational Oncology Mainz and Immunology (TrOn) in Mainz. With the Illumina HiSeq 2000 instrument, the genetic material of cells can be completely decoded within a few days.
"The performance of TrOn as an innovation center and hub of the CI3 regional network of science and business is strengthened by this technology. This is therefore another important step to make Mainz a globally competitive center for personalized medicine," says Univ.-Prof. Dr. Ugur Sahin, director of TrOn. “The new technology allows us to examine the genetic information in tumor and immune cells quickly and inexpensively in order to gain a better understanding of the interplay of cancer treatment and immune system. This is necessary to develop customized therapies for individual patients."
"The new instrument is eight times more powerful than previous methods," says Dr. John Castle, head of Bioinformatics/Genomics at TrOn. "This represents not only a significant reduction of time and costs, but also more information that must be analyzed. For this, we are well positioned by our cooperation with the University of Mainz Center for High Performance Computing (ZDV)."
Understanding the characteristics of individual cancer patients is the basis for a customized treatment and thus critical to a successful therapy. "Individualized" and targeted medicine offers a great promise to significantly improve cancer therapy, both decreasing the cost of health care and improving patient lives. The dramatically increased ability to decode genomes ushered in by this next era of DNA sequencing makes the vision possible.
University President Univ.-Prof. Dr. Georg Krausch, a member of the successful Mainz "City of Science 2011" team, commented: "This is one of the puzzle pieces which we want at our site: cutting-edge research to resolve major social challenges."Press contact
PET imaging tracks Zika virus infection, disease progression in mouse model
20.09.2017 | US Army Medical Research Institute of Infectious Diseases
'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
20.09.2017 | Life Sciences
20.09.2017 | Power and Electrical Engineering
20.09.2017 | Physics and Astronomy